Ion Titapiccolo, Jasmine https://orcid.org/0000-0001-5514-8182
Neri, Luca
Schaufler, Thilo https://orcid.org/0000-0003-1886-829X
Arens, Hans-Jurgen
Usvyat, Len
Stuard, Stefano
Soro, Marco
Funding for this research was provided by:
Vifor Pharma
Article History
Received: 15 October 2024
Accepted: 10 December 2024
First Online: 2 January 2025
Declarations
:
: Jasmine Ion Titapiccolo, Luca Neri, Hans-Juergen Arens, Len Usvyat, Stefano Stuard are employees of Fresenius Medical Care. Marco Soro and Thilo Schaufler are employees of CSL Vifor and have CSL share options. Hans-Juergen Arens has share options/ownership in Fresenius Medical Care, Abbott Laboratories, and AbbVie Inc. Len Usvyat has share options/ownership in Fresenius Medical Care and he is inventor of patents in the field of dialysis. Len Usvyat is an advisory board member for Privacy Analytics Inc.
: All the patients consented to their data being used for secondary data analysis and research. Ethical approval was waived by the Ethics Committee of the Hospital Clinic of Barcelona, Spain with the protocol number Reg. HCB/2022/0586. All research was performed in accordance with relevant guidelines and regulations and in particular in accordance with the World Medical Association Declaration of Helsinki regarding the ethical principles for medical research involving human subjects. Patients were involved in the initial design of the study through feedback gathered in patient-reported outcomes from previous quality of life assessments. Additionally, the results of this study will be shared with the patient community through appropriate channels to inform them of the findings and potential implications for future treatment strategies. We are committed to patient-centered research while always safeguarding patient confidentiality.